Rotigotine Patch Suppliers & Bulk Manufacturers
Available Forms: Patches
Available Strengths: 2 mg/24 hr, 4 mg/24 hr, 6 mg/24 hr, 8 mg/24 hr, and 12 mg/24 hr
Reference Brands: Neupro
Category:
Transdermal Patches
The rotigotine patch delivers a dopamine agonist steadily through the skin, stimulating dopamine receptors to improve motor function. Benefits include symptom relief in Parkinson’s disease and RLS, reduced fluctuations, improved adherence with once-daily application, and enhanced quality of life due to consistent therapeutic delivery and symptom control.
Rotigotine patch is available in Patches
and strengths such as 2 mg/24 hr, 4 mg/24 hr, 6 mg/24 hr, 8 mg/24 hr, and 12 mg/24 hr.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Rotigotine patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Rotigotine patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Rotigotine transdermal patches (Neupro) are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and MDR standards. In the US, FDA approval involved extensive clinical validation and safety assessments, while in the EU, CE marking certifies conformity with MDR standards. These products undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to reliable, approved rotigotine patches supporting Parkinson’s disease and RLS treatment worldwide, improving patient outcomes and healthcare safety.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing